{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:55:17Z","timestamp":1784782517458,"version":"3.55.0"},"reference-count":36,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Anemia is a frequent complication of ulcerative colitis, and is frequently caused by iron deficiency. Oral iron supplementation displays high rates of gastrointestinal adverse effects. However, the formulation of sucrosomial iron (SI) has shown higher tolerability. We performed a prospective study to compare the effectiveness and tolerability of oral SI and intravenous ferric carboxy-maltose (FCM) in patients with ulcerative colitis in remission and mild-to-moderate anemia. Patients were randomized 1:1 to receive 60 mg\/day for 8 weeks and then 30 mg\/day for 4 weeks of oral SI or intravenous 1000 mg of FCM at baseline. Hemoglobin and serum levels of iron and ferritin were assessed after 4, 8, and 12 weeks from baseline. Hemoglobin and serum iron increased in both groups after 4 weeks of therapy, and remained stable during follow up, without significant treatment or treatment-by-time interactions (p = 0.25 and p = 0.46 for hemoglobin, respectively; p = 0.25 and p = 0.26 for iron, respectively). Serum ferritin did not increase over time during SI supplementation, while it increased in patients treated with FCM (treatment effect, p = 0.0004; treatment-by-time interaction effect, p = 0.0002). Overall, this study showed that SI and FCM displayed similar effectiveness and tolerability for treatment of mild-to-moderate anemia in patients with ulcerative colitis under remission.<\/jats:p>","DOI":"10.3390\/nu13020608","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T22:41:25Z","timestamp":1613169685000},"page":"608","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8653-1790","authenticated-orcid":false,"given":"Lorenzo","family":"Bertani","sequence":"first","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-1346","authenticated-orcid":false,"given":"Domenico","family":"Tric\u00f2","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Zanzi","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Baiano Svizzero","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Coppini","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"de Bortoli","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6387-6443","authenticated-orcid":false,"given":"Massimo","family":"Bellini","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-617X","authenticated-orcid":false,"given":"Luca","family":"Antonioli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Blandizzi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santino","family":"Marchi","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/j.amjmed.2003.12.011","article-title":"Prevalence and outcomes of anemia in inflammatory bowel disease: A systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.3748\/wjg.15.4659","article-title":"Anemia and inflammatory bowel diseases","volume":"15","author":"Gomollon","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.2009.009985","article-title":"Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment","volume":"95","author":"Bergamaschi","year":"2010","journal-title":"Haematologica"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/apt.14920","article-title":"Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: A population-based cohort study","volume":"48","author":"Eriksson","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/ecco-jcc\/jjx077","article-title":"Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort\u2014An ECCO-EpiCom study","volume":"11","author":"Burisch","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2010.151","article-title":"Diagnosis and management of iron deficiency anemia in patients with IBD","volume":"7","author":"Stein","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The ferric carboxymaltose (FERINJECT) randomized controlled trial","volume":"103","author":"Kulnigg","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease","volume":"141","author":"Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/00365521.2013.819442","article-title":"Anemia and iron deficiency in inflammatory bowel disease: An open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life","volume":"48","author":"Befrits","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40265-018-0885-7","article-title":"Ferric carboxymaltose: A review in iron deficiency","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lamb, C.A., Kennedy, N.A., Raine, T., Hendy, P.A., Smith, P.J., Limdi, J.K., Hayee, B., Lomer, M.C.E., Parkes, G.C., and Selinger, C. (2019). British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 68.","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/flgastro-2013-100388","article-title":"Anaemia in inflammatory bowel disease","volume":"5","author":"Dibb","year":"2014","journal-title":"Frontline Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Gomez-Ramirez, S., Brilli, E., Tarantino, G., and Munoz, M. (2018). Sucrosomial((R)) iron: A new generation iron for improving oral supplementation. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040097"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11739-018-1993-9","article-title":"Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia","volume":"14","author":"Abbati","year":"2019","journal-title":"Intern. Emerg. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bertani, L., Mumolo, M.G., Tapete, G., Albano, E., Baiano Svizzero, G., Zanzi, F., Ceccarelli, L., Bellini, M., Marchi, S., and Costa, F. (2020). Fecal calprotectin: Current and future perspectives for inflammatory bowel disease treatment. Eur. J. Gastroenterol. Hepatol.","DOI":"10.1097\/MEG.0000000000001731"},{"key":"ref_18","unstructured":"WHO, UNICEF, and UNU (1998). Iron Deficiency Anemia: Assessment, Prevention and Control, Report of a Joint WHO\/UNICEF\/UNU consultation."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.23736\/S1121-421X.19.02572-8","article-title":"Oral iron supplementation with Feralgine(R) in inflammatory bowel disease: A retrospective observational study","volume":"65","author":"Vernero","year":"2019","journal-title":"Minerva Gastroenterol. E Dietol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E404","DOI":"10.1002\/ajh.25299","article-title":"Effectiveness of oral iron supplementation in treatment of anemia associated with pediatric ulcerative colitis flare","volume":"93","author":"Egberg","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ajcn\/78.1.145","article-title":"Efficacy and tolerability of low-dose iron supplements during pregnancy: A randomized controlled trial","volume":"78","author":"Makrides","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjmed.2005.01.065","article-title":"Are we giving too much iron? Low-dose iron therapy is effective in octogenarians","volume":"118","author":"Rimon","year":"2005","journal-title":"Am. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/MIB.0b013e31827febbb","article-title":"A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease","volume":"19","author":"Vavricka","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_26","unstructured":"Bastida, G. (2016). Efficacy and tolerability of Sucrosomial iron supplementation in IBD patients with iron deficiency anemia and intolerance to iron oral salts. Expert Rev. Hematol., 9."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1080\/14656566.2017.1391790","article-title":"Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice","volume":"18","author":"Stein","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/00365520902839667","article-title":"Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study","volume":"44","author":"Lindgren","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5009\/gnl15373","article-title":"Comparison of the efficacies of parenteral iron sucrose and oral iron sulfate for anemic patients with inflammatory bowel disease in Korea","volume":"10","author":"Han","year":"2016","journal-title":"Gut Liver"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","article-title":"Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease\u2014A randomized, controlled, open-label, multicenter study","volume":"100","author":"Schroder","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/00365520510023198","article-title":"Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease","volume":"40","author":"Erichsen","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MIB.0000000000001089","article-title":"Iron supplements modulate colon microbiota composition and potentiate the protective effects of probiotics in dextran sodium sulfate-induced colitis","volume":"23","author":"Constante","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejps.2017.10.021","article-title":"Sucrosomial(R) iron absorption studied by in vitro and ex-vivo models","volume":"111","author":"Fabiano","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Fabiano, A., Brilli, E., Mattii, L., Testai, L., Moscato, S., Citi, V., Tarantino, G., and Zambito, Y. (2018). Ex vivo and in vivo study of sucrosomial\u00ae iron intestinal absorption and bioavailability. Int. J. Pharm. Sci., 19.","DOI":"10.3390\/ijms19092722"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.gtc.2017.08.011","article-title":"Vitamins and minerals in inflammatory bowel disease","volume":"46","author":"Ghishan","year":"2017","journal-title":"Gastroenterol. Clin. North Am."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000505368","article-title":"Nutrition in inflammatory bowel disease","volume":"101","author":"Schreiner","year":"2020","journal-title":"Digestion"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/2\/608\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:23:35Z","timestamp":1760160215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/2\/608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["nu13020608"],"URL":"https:\/\/doi.org\/10.3390\/nu13020608","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}